No services found
No Products found
100ug, 50ug
ProteoGenix
COVID-19 products
Escherichia coli (E. coli)
SARS-CoV-2 Accessory Protein 9b (also known as ORF9b) is a small, non-structural protein encoded by the SARS-CoV-2 viral genome. It is approximately 98 amino acids in length and has a molecular weight of 11 kDa. The protein is composed of two alpha-helices and a beta-sheet, giving it a compact, globular structure. It is highly conserved among different strains of SARS-CoV-2, with only a few amino acid variations observed.
SARS-CoV-2 Accessory Protein 9b is a multifunctional protein that has been shown to play a role in viral replication, immune evasion, and pathogenesis. Its exact mechanism of action is still being studied, but several studies have provided insights into its various activities.
One of the main functions of 9b is its ability to suppress the host’s innate immune response. It has been shown to inhibit the production of type I interferons, which are important antiviral proteins that help the body fight off infections. This allows the virus to replicate and spread more efficiently within the host.
In addition, 9b has been found to interact with host cell proteins involved in the regulation of cell death. This suggests that it may play a role in the virus’s ability to cause severe disease by disrupting the balance between cell survival and death.
Studies have also shown that SARS-CoV-2 Accessory Protein 9b is essential for viral replication. It has been found to interact with other viral proteins, such as the nucleocapsid protein, to form a complex that is important for the assembly of new virus particles. This interaction is crucial for the virus’s ability to replicate and spread within the host.
Moreover, 9b has been shown to localize to the endoplasmic reticulum (ER) of infected cells, which is a site of viral replication. This suggests that it may play a role in the formation of viral replication complexes and the production of new viral particles.
Given its various activities and essential role in viral replication, SARS-CoV-2 Accessory Protein 9b has been identified as a potential target for antiviral therapies. Inhibiting its function could potentially limit viral replication and reduce the severity of COVID-19.
In addition, 9b has also been identified as a potential diagnostic marker for COVID-19. Antibodies against 9b have been found in patients with COVID-19, suggesting that it could be used as a biomarker for infection. Furthermore, the protein’s high conservation among different strains of SARS-CoV-2 makes it a promising candidate for the development of vaccines and diagnostic tests.
SARS-CoV-2 Accessory Protein 9b is a small but important protein in the viral genome. Its structure and activities have been extensively studied, and it has been found to play a crucial role in viral replication, immune evasion, and pathogenesis. Further research on this protein could lead to the development of new treatments and diagnostic tools for COVID-19.
Reviews
There are no reviews yet.
Your email address will not be published. Required fields are marked *
Your review *
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
Send us a message from the form below
First name
Last name
Email address
Lab / Company
Phone number
Message
send
Your cart is currently empty.